How does Adamax differ from Semax?

Semax is ACTH(4-7)-Pro-Gly-Pro with an N-terminal acetyl group. Adamax replaces the acetyl group with an adamantane moiety — the same cage-like hydrocarbon structure found in the Alzheimer's drug memantine. This is claimed to increase lipophilicity, blood-brain barrier penetration, and half-life. However, no published studies compare Adamax to Semax — these claims are based on chemical reasoning, not experimental evidence.

Has Adamax been studied in humans?

No. Adamax has zero PubMed-indexed studies — not in humans, not in animals, not even in vitro. All claims about its effects are extrapolated from Semax research. Semax has been studied in Russia for decades and is available as a prescription nootropic there, but Semax research is largely published in Russian-language journals with limited international peer review. Adamax itself is entirely unstudied and should be treated as an experimental research chemical.

Content reviewed by clinical research staff

Last reviewed: March 2026Sources: PubMed, FDA, WADA Prohibited List

Evidence graded using the PeptideScholar A-D system.

Adamax

Modified Semax analog (adamantane-capped)7 amino acids

DLimited Data

Fair Credibility

2 cited studies | Evidence level D

Not FDA Approved

Adamax is a modified, more lipophilic analog of Semax in which the N-terminal acetyl group is replaced with an adamantane moiety. Semax itself is a synthetic fragment of adrenocorticotropic hormone (ACTH(4-7)) with a C-terminal Pro-Gly-Pro tripeptide. The adamantane modification is claimed to increase blood-brain barrier penetration and extend half-life. There are zero published studies on Adamax specifically — all evidence is extrapolated from Semax research.

Mechanism of Action

Mechanism is extrapolated from Semax: Semax increases brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) expression, modulates dopaminergic and serotonergic systems, and upregulates neuroprotective gene expression. The adamantane group (also found in memantine, an NMDA antagonist for Alzheimer's) may confer additional membrane affinity and CNS penetration, but this claim is unverified for Adamax.

Benefits

Semax increases BDNF expression and provides neuroprotection in cerebral ischemia models^[1]
Semax modulates dopaminergic and serotonergic brain systems — shown in rodent studies^[2]
Semax shows nootropic and analgesic effects in animal models
The adamantane modification MAY improve brain penetration, but this is theoretical — no studies confirm this

This content is for informational purposes only and does not constitute medical advice.

Adamax - Dosing in Published Research

Reported routes: Intranasal, Subcutaneous injection

No established dosing. Adamax is a research chemical with no clinical studies. Anecdotal reports suggest intranasal doses of 100–400 μg, but this is entirely unvalidated. Semax is used in Russia at 0.1–1.0 mg intranasally for cognitive disorders. Extrapolating from Semax data is speculative and may not reflect Adamax pharmacology.

The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.

Side Effects

No safety data exists for Adamax specifically — zero published studies
Semax has a favorable safety profile in Russian clinical use, but Adamax may differ
Unknown long-term neurological effects
No regulatory approval in any jurisdiction

Considering peptide research?

Adamax is not FDA-approved. Always consult a licensed healthcare provider before considering any peptide.

Use the Peptide Finder

Use the guided tool to narrow the safest next step.

Always consult a professional

Research & Evidence

AnimalPMID: 24661604

The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia.

BMC Genomics, 2014

Semax significantly altered gene expression in rat brain following ischemia, upregulating neuroprotective and vascular remodeling genes

AnimalPMID: 16362768

Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Neurochem Res, 2005

Semax increased dopamine and serotonin turnover in rodent brain regions, providing mechanistic basis for nootropic effects

References

1.The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia.. BMC Genomics, 2014. "Semax significantly altered gene expression in rat brain following ischemia, upregulating neuroprotective and vascular remodeling genes" [PMID: 24661604]
2.Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.. Neurochem Res, 2005. "Semax increased dopamine and serotonin turnover in rodent brain regions, providing mechanistic basis for nootropic effects" [PMID: 16362768]

Recommended Resources

The Peptide Protocols Handbook

Evidence-based reference guide covering mechanisms, research, and clinical applications.

View on Amazon

Third-Party Peptide Testing

Independent lab analysis to verify peptide purity and authenticity.

Learn More

Links may be affiliate links. See our disclosure.

Research Supplies

Equipment for responsible research-grade peptide handling and administration.

Alcohol Prep Pads (200 ct)

Sterile 70% isopropyl pads for injection site preparation — essential for subcutaneous protocols.

$5–10View on Amazon

1mL Insulin Syringes (28G)

Thin-gauge 28G syringes for subcutaneous peptide administration with minimal discomfort.

$10–18View on Amazon

Sharps Disposal Container (1 Qt)

Biohazard-safe sharps container for responsible disposal of used syringes.

$8–15View on Amazon

Digital Milligram Scale (0.001g)

High-precision scale for accurate measurement of peptide powder before reconstitution.

$20–40View on Amazon

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Adamax FAQ

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.